Gly-oxide Liquid
NDC 63029-500
Product Information
Gly-oxide (carbamide peroxide) is a OTC MONOGRAPH DRUG-approved product labeled by Medtech Products Inc.. This medication is used to treat earwax buildup. It is supplied as a liquid for oral administration. This product entry covers the primary NDC 63029-500 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 63029-500?
What are the uses of this product?
What are Active Ingredients of this product?
- CARBAMIDE PEROXIDE 100 mg/mL - A urea peroxide compound that is commonly used in tooth whitening agents; topical anti-infective agents, and earwax remover.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CARBAMIDE PEROXIDE (UNII: 31PZ2VAU81)
- CARBAMIDE PEROXIDE (UNII: 31PZ2VAU81) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- GLYCERIN (UNII: PDC6A3C0OX)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)
- SODIUM STANNATE (UNII: NJ7C1V83KG)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1048144 - Gly-Oxide Oral Cleanser 10 % Mucous Membrane Topical Solution
- RxCUI: 1048144 - carbamide peroxide 100 MG/ML Mucous Membrane Topical Solution [Gly-Oxide]
- RxCUI: 1048144 - Glyoxide 10 % Mucous Membrane Topical Solution
- RxCUI: 1048144 - Gly-Oxide 100 MG/ML Mucous Membrane Topical Solution
- RxCUI: 582808 - carbamide peroxide 10 % Mucous Membrane Topical Solution
* Please review the full disclaimer at the bottom of this page.